Fatty liver disease is becoming one of the fastest-growing health problems in the world. A common type called non-alcoholic fatty liver disease, or NAFLD, now affects around one in four people globally.
Many people have never heard of it, and even those who have may not realize they are living with the condition. In the early stages, fatty liver disease usually causes no clear symptoms. People can feel completely normal while fat slowly builds up inside the liver.
The liver is one of the body’s most important organs. It helps process food, store energy, remove toxins, and support digestion.
When too much fat collects in the liver, the organ can become inflamed and damaged over time. If the disease keeps getting worse, it may lead to serious health conditions such as type 2 diabetes, heart disease, liver scarring, liver failure, and even liver cancer.
Doctors are especially concerned because there is currently no approved medicine specifically designed to treat NAFLD. Right now, the best treatment is changing daily habits. Patients are usually advised to lose weight, exercise regularly, and reduce calories in their diet.
These lifestyle changes can help lower fat levels in the liver, especially during the early stages of the disease. However, once the condition becomes more severe, treatment becomes much more difficult.
A more dangerous stage of fatty liver disease is known as non-alcoholic steatohepatitis, or NASH. In this stage, the liver becomes inflamed and damaged.
Some people with NASH eventually develop cirrhosis, which is severe liver scarring that can permanently damage liver function. Because there are no approved medicines for NASH either, researchers around the world are urgently searching for new treatment options.
A research team in China may have discovered an important clue that could lead to future treatments. The team was led by Mengyao Wu from Guangzhou University. The researchers focused on a special molecule in the liver called Adgrf1. This molecule is found mainly in liver cells and may play an important role in how the liver handles fat and sugar.
To study the molecule, scientists fed mice a high-fat diet to create a condition similar to early-stage fatty liver disease in humans. They discovered that the amount of Adgrf1 in the liver dropped sharply in these mice.
This finding suggested that changes in Adgrf1 levels may happen very early in the disease process. It could even serve as a warning sign before more serious damage develops.
The researchers then explored what would happen if they changed the amount of Adgrf1 in the mice. When they reduced the levels of this molecule, the animals began showing signs linked to diabetes. Their blood sugar and insulin levels increased, suggesting that Adgrf1 may help control how the body manages sugar and fat.
Next, the team carried out another important experiment. They blocked Adgrf1 in mice that already had fatty liver disease. Surprisingly, the liver health of these mice improved. This result raised the exciting possibility that targeting Adgrf1 could help treat fatty liver disease rather than simply identifying it early.
The scientists wanted to know whether the same pattern existed in humans. To test this, they examined liver samples from patients with different stages of NAFLD. The results closely matched what they had seen in the mice. Patients with more severe fatty liver disease had higher levels of Adgrf1 in their liver tissue.
This discovery could become very important for future medicine development. Because Adgrf1 is found mainly in the liver, researchers believe it may be possible to design drugs that target this molecule directly while causing fewer side effects in other parts of the body.
Many medicines fail because they affect multiple organs and create unwanted problems elsewhere, so a liver-focused target could offer a major advantage.
Even though the findings are promising, scientists caution that more research is still needed. Studies in mice do not always produce the same results in humans.
Researchers must now better understand exactly how Adgrf1 works and determine whether blocking it is safe over the long term. Clinical trials in humans would also be needed before any treatment could become widely available.
Still, experts say this study offers new hope for millions of people affected by fatty liver disease. As rates of obesity and type 2 diabetes continue to rise worldwide, cases of NAFLD are also increasing rapidly. Many doctors now see fatty liver disease as one of the biggest future threats to public health.
For now, maintaining a healthy lifestyle remains the best way to protect the liver. Regular exercise, weight control, healthy eating habits, and limiting highly processed foods may help reduce fat buildup in the liver.
Some recent research has also suggested that coffee consumption may help lower the risk of liver disease and liver cancer. Other studies indicate that anti-inflammatory diets, dairy foods, and enough vitamin D may also support liver health.
Scientists around the world are continuing to explore how the liver works and what causes fatty liver disease to become more severe. Every new discovery brings researchers one step closer to finding better ways to prevent and treat this growing condition.
If you care about liver health, please read studies that refined fiber is link to liver cancer, and the best and worst foods for liver health.
For more health information, please see recent studies about how to boost your liver naturally, and simple ways to detox your liver.
The study discussed in this article was published in the journal eLife.
Copyright © 2026 Knowridge Science Report. All rights reserved.
